Key Events This Week
22 Jun: Stock surged 5.10% to Rs.402.70
23 Jun: Slight dip of 0.45% amid Sensex decline
24 Jun: Upgrade to Hold rating and mildly bullish momentum noted
25 Jun: Formation of Golden Cross, stock closed lower at Rs.392.50 (-2.28%)
Jul 30, 01:17 PM
BSE+NSE Vol: 9.58 k

Gujarat Themis Biosyn Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Gujarat Themis Biosyn Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in daily price performance, key technical indicators such as MACD, RSI, and moving averages reveal a complex picture that investors should carefully analyse before making decisions.
Read full news article
Gujarat Themis Biosyn Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Gujarat Themis Biosyn Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest an improving outlook for this small-cap pharmaceutical player. Recent upgrades in technical grades and a 3.27% day gain underscore renewed investor interest, positioning the stock for potential further gains amid mixed sector dynamics.
Read full news article
Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the company’s technical indicators reveal a cautiously optimistic outlook, prompting a reassessment of its market stance from Sell to Hold.
Read full news article
Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Sell to Hold as of 23 June 2026. This change reflects improving technical indicators and a cautiously optimistic outlook despite a modest day decline of 2.28% to close at ₹392.50 on 29 June 2026.
Read full news article
22 Jun: Stock surged 5.10% to Rs.402.70
23 Jun: Slight dip of 0.45% amid Sensex decline
24 Jun: Upgrade to Hold rating and mildly bullish momentum noted
25 Jun: Formation of Golden Cross, stock closed lower at Rs.392.50 (-2.28%)

The 50-day moving average has crossed above the 200-day moving average for Gujarat Themis Biosyn Ltd, signalling a golden cross on 25 Jun 2026. Yet, the stock declined 2.28% on the same day, while monthly technical indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context.
Read full news articleNo Upcoming Board Meetings
Gujarat Themis Biosyn Ltd has declared 67% dividend, ex-date: 04 Sep 25
Gujarat Themis Biosyn Ltd has announced 1:5 stock split, ex-date: 10 Oct 23
Gujarat Themis Biosyn Ltd has announced 1:2 bonus issue, ex-date: 09 Aug 24
No Rights history available